Randomized Phase II Study of Olaparib Maintenance Following Cabazitaxel-Carboplatin Induction Chemotherapy in Men With Aggressive Variant Prostate Cancer (AVPC)
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2019
At a glance
- Drugs Olaparib (Primary) ; Cabazitaxel; Carboplatin; Prednisone
- Indications Carcinoma; Prostate cancer
- Focus Therapeutic Use
- 11 Jan 2019 Planned End Date changed from 1 Oct 2021 to 1 Oct 2020.
- 11 Jan 2019 Planned primary completion date changed from 27 Oct 2020 to 1 Oct 2020.
- 31 Aug 2018 Biomarkers information updated